Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dally

Showing results (551-560 of 579) with videos related to

Pageof 58
Sort By:
Sante Publique (Vandoeuvre-Les-Nancy, France)|February 1, 2018
[A plea for introduction of hepatitis B vaccination at birth in Côte d'Ivoire]Assemien Boa, Alfred Douba, Tah Bi N Guessan, et al.
British Journal of Haematology|July 14, 2026
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective studyTzvika Porges, Tsofia Levi, Eldad J Dann, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Current Biology : CB|May 22, 2012
The role of a pseudo-response regulator gene in life cycle adaptation and domestication of beetPierre A Pin, Wenying Zhang, Sebastian H Vogt, et al.
Biomolecules|April 30, 2025
Calcium-Sensing Receptor as a Novel Target for the Treatment of Idiopathic Pulmonary FibrosisKasope Wolffs, Renjiao Li, Bethan Mansfield, et al.
Plos One|May 24, 2011
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteersSandhya Vasan, Arlene Hurley, Sarah J Schlesinger, et al.
Nature Medicine|February 23, 2021
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencingYael C Cohen, Mor Zada, Shuang-Yin Wang, et al.
Nature Communications|January 24, 2024
Sublimed C<sub>60</sub> for efficient and repeatable perovskite-based solar cellsAhmed A Said, Erkan Aydin, Esma Ugur, et al.
Annals of Hematology|January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysisIrit Avivi, Chava Perry, Yafit Segman, et al.
Pageof 58

Showing results (551-560 of 579) with videos related to

Sort By:
Pageof 58
Sante Publique (Vandoeuvre-Les-Nancy, France)|February 1, 2018
[A plea for introduction of hepatitis B vaccination at birth in Côte d'Ivoire]Assemien Boa, Alfred Douba, Tah Bi N Guessan, et al.
British Journal of Haematology|July 14, 2026
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective studyTzvika Porges, Tsofia Levi, Eldad J Dann, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Current Biology : CB|May 22, 2012
The role of a pseudo-response regulator gene in life cycle adaptation and domestication of beetPierre A Pin, Wenying Zhang, Sebastian H Vogt, et al.
Biomolecules|April 30, 2025
Calcium-Sensing Receptor as a Novel Target for the Treatment of Idiopathic Pulmonary FibrosisKasope Wolffs, Renjiao Li, Bethan Mansfield, et al.
Plos One|May 24, 2011
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteersSandhya Vasan, Arlene Hurley, Sarah J Schlesinger, et al.
Nature Medicine|February 23, 2021
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencingYael C Cohen, Mor Zada, Shuang-Yin Wang, et al.
Nature Communications|January 24, 2024
Sublimed C<sub>60</sub> for efficient and repeatable perovskite-based solar cellsAhmed A Said, Erkan Aydin, Esma Ugur, et al.
Annals of Hematology|January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysisIrit Avivi, Chava Perry, Yafit Segman, et al.
Pageof 58